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Abstract 
To study the nature of the glucose binding pocket of the renal Na +/D-glucose cotransporter, we have evaluated the inhibitory potency 
of various alkylglucosides (AG) on sodium-dependent D-glucose uptake into hog kidney brush border membrane vesicles (BBMV). 
Inhibition at 0.1 mM AG level was found to be strongly dependent on the anomeric onfiguration, on the length and on the flexibility of 
the side chain, fl-n-AG inhibited transport significantly more effectively compared to the corresponding a-anomer (n-octylglucoside: 
a-anomer 15%, /3-anomer 84%) and AG with an unsaturated n-alkenyl side chain were significantly less effective inhibitors than the 
corresponding saturated compound (cis/trans 3-n-/3-hexenylglucoside 53% and 32%, /3-n-hexylglucoside 76%). A series of fl-n-AG 
increasing in side chain length from 1 to 13 carbon atoms revealed a global maximum in the inhibition pattern when /3-AG with side 
chains ranging from 8 to 11 carbon atoms were used, thus /3-methylglucoside inhibited glucose transport by 13%, /3-n-nonylglucoside by 
92%, and /3-n-tridecylglucoside showed no effect. Kinetic analysis of inhibition by fl-n-octylglucoside revealed a fully competitive type 
of inhibition with an apparent K i of t0 + 2 /xM. n-Octylglucoside at 0.1 mM did not inhibit sodium-dependent L-alanine uptake; 
similarly, n-octylmannoside at 0.1 mM level did not affect D-glucose uptake. These results suggest that the inhibition of sodium-depen- 
dent D-glucose uptake was, at least in the concentration range tested (up to 0.1 mM), not due to a detergent effect of AG, but due to 
interaction with the carrier. Optimum interaction requires a /3-anomer with a glycosidic bond that places the alkyl chain into an equatorial 
position with regard to the D-glucose molecule and the two main determinants of the sugar ecognition site C2 and C3. In addition, the 
alkyl chain has to be highly flexible. The alkyl chains thus apparently interact with hydrophobic sites at the carrier in a slightly coiled 
conformation, thereby AG with a chain length up to 6 carbon atoms interact only with one hydrophobic site, AG with higher chain length 
probably with two sites. 
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1. Introduction 
Several members of the Na+/D-glucose cotransporter 
(SGLT) family have been identified recently by cloning 
experiments: the high affinity Na+/D-glucose cotrans- 
porter from rabbit small intestine [1] and kidney [2], from 
human [3], hog [4] and rat kidney [5] and the low affinity 
Na+/o-glucose cotransporter f om human kidney [6,7]. 
Analysis of the deduced amino acid sequences according 
to the hydrophobic moment plot method [8] showed the 
Na+/D-glucose cotransporter most likely to be a mem- 
brane protein with 12 membrane spanning a-helical do- 
mains. In addition, mutagenesis data identified amino acids 
critically important for the interaction with D-glucose and 
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sodium [9]. Despite this information the knowledge about 
the topology and the assembly of different functional 
domains of the transporter is still very limited. 
The investigation of the functional and kinetic proper- 
ties of sodium-dependent D-glucose cotransport by measur- 
ing the uptake of radiolabeled substrates into isolated 
plasma membranes [10] obtained from hog renal cortex 
revealed a low affinity for D-glucose, K m = 1.3 mM, and a 
high sensitivity for the naturally occurring /3-glucoside 
phlorizin, K i = 1.2 /zM [11]. The about 1000-fold in- 
creased affinity for phlorizin compared to D-glucose can 
only be explained by the presence of multiple binding sites 
on the transporter, one being identical with the glucose 
binding site. The high affinity inhibitor phlorizin seems to 
bind to the substrate recognition site with the D-glucose 
moiety and to hydrophobic sites on the transporter with the 
/3-glucoside side chain [12]. Thus the common motif of 
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high affinity inhibitors is their capability of accommodat- 
ing these multiple sites. 
Beside phlorizin, which exhibits an aglucon moiety of a 
rather complicated chemical structure, there are a few 
reports of simple AG employed as inhibitors for the 
Na+/D-glucose cotransport. AG are substrates of sodium- 
dependent D-glucose transport into hamster small intestine 
[13] and inhibitors of sodium-dependent D-glucose uptake 
into rabbit, rat and human small intestine brush border 
membrane vesicles [14]. 
In order to explore the spacing between multiple sites 
on the transporter, we have systematically investigated the 
inhibitory potency of AG on sodium-dependent D-glucose 
uptake into BBMV obtained from hog renal cortex. Taking 
the simple chemical structure of AG into account, a series 
of homologs can be easily synthesized and evaluated as 
inhibitors. In the present study we attempt to demonstrate 
that despite their detergent potential, AG can be used as 
high affinity inhibitors for the Na+/D-glucose cotrans- 
porter at low concentrations and that they are valuable 
tools for the investigation of the assembly of different sites 
on the transporter molecule in its membrane mbedded 
state. 
2. Materials and methods 
2.1. Materials 
All chemicals used in this study were of the highest 
purity available. Radiolabeled substrates D-[6-3H]glucose 
(1 TBq/mmol) and L-[2,3-3H]alanine (2.18 TBq/mmol) 
were obtained from Amersham-Buchler (Braunschweig, 
Germany). The fl-AG of phenyl, methyl and n-/3-pentyl to 
n-/3-dodecyl and oz-phenyl-, n-ol-octyl-, and n-o~-decylglu- 
coside were products of Sigma (Deisenhofen, Germany). 
o~-n-Octylmannoside, fl-n-tridecylglucoside and cis- and 
trans-n-3-hexenyl-/3-glucoside were synthesized in our lab- 
oratory as described below. 
2.2. Alkylglucoside synthesis 
AG were synthesized by glycosylation of the corre- 
sponding alkanol with a-acetobromoglucose a  described 
by Weber and Benning [15]. Synthesized AG and interme- 
diates were purified according to the 'flash' method [16] 
on Silica Gel 32-63 mesh, 60A (E. Merck, Darmstadt, 
Germany) using the solvent systems light petroleum/ethyl 
acetate  3:1 fo r  acety la ted  and ethy l  
acetate/methanol/water 27:3:1 for deacetylated com- 
pounds. Final products were homogenous on thin-layer 
chromatography plates (Silica Gel, 60A, E. Merck, Darm- 
stadt, Germany) developed in the above indicated solvent 
systems. Identity and purity was further established by I H 
(500 MHz) and 13C (125.8 MHz) NMR spectroscopy on a 
Bruker AM 500 in CDC13 (acetylated compounds) or 
CD3OD solution (deacetylated compounds) with tetram- 
ethylsilane as a standard, n-Octyl-a-D-mannoside was syn- 
thesized by glycosylation of n-octanol with /3- 
acetobromomannose as described above. /3- 
Acetobromomannose was prepared from D-mannose by 
subsequent reaction with sodium acetate in acetic anhy- 
dride and hydrobromic acid in acetic acid according to the 
method of Rosevear et al. [17]. 
2.3. Isolation of  renal brush border membranes 
Hog kidneys were obtained in a local slaughterhouse 
immediately after killing of the animals. Brush border 
membrane vesicles (BBMV) were isolated from hog kid- 
ney cortex by a calcium precipitation method escribed by 
Vannier et al. [18] and modified in this laboratory [11]. 
Final BBMV were suspended at a concentration f 20 mg 
protein/ml in mannitol Hepes Tris (MHT) buffer (100 
mmol/1 mannitol, 20 mmol/l Hepes-Tris, pH 7.4). The 
purity of the preparation was routinely determined by 
assaying the marker enzyme alkaline phosphatase (E.C. 
3.1.3.1.) which was enriched 9- to 12-fold. BBMV were 
stored at - 70°C until use and diluted to a concentration f
10 mg protein/ml with MHT buffer for transport studies. 
2.4. Transport measurements 
Uptake of radiolabeled substrates was determined at 
22°C with the rapid filtration technique as described ini- 
tially by Hopfer et al. [19]. The uptake was initiated by 
adding 20 /xl BBMV suspension (200 /xg protein) to 50 
/zl incubation media to give 100 mmol/l mannitol, 20 
mmol/1 Hepes-Tris (pH 7.4), 100 retool/1 NaSCN or 
KSCN, 0.1 mmol/l  substrate (4.17 tzCi D-[3H]glucose or 
t-[2,3-3H]alanine) and the indicated inhibitor concentra- 
tions. The incubation was terminated after 5 s by adding 1 
ml ice-cold stop solution (100 mmol/l NaCI, 100 mmol/l 
mannitol, 20 mmol/1 Hepes-Tris (pH 7.4) and 0.2 mmol/1 
phlorizin) followed by rapid filtration of the suspension 
through prewetted 0.45 /~m nitrocellulose filters. After 
rinsing with 3.5 ml ice-cold stop solution the wet filters 
were dissolved in 7 ml scintillation fluid and counted for 
radioactivity in a liquid scintillation counter. 'Equilibrium' 
uptakes were measured under the same conditions after 90 
min incubation. 
Substrate uptakes presented are mean values _ S.E. from 
at least three independent experiments, each performed in 
duplicate or triplicate. For statistical comparisons, Student's 
t-test was used. Data for the sodium-dependent D-glucose 
uptake are corrected for the sodium-independent up ake, 
measured in the presence of a potassium gradient. 
Sodium-independent uptake ranged from 4 to 6% of the 
total substrate uptake. 
2.5. Protein determinations 
Protein was determined according to the method of 
Lowry et al. [20] using bovine serum albumin as standard. 
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3. Results 
To explore the structural requirements of glucoside side 
chains for optimal interaction with hydrophobic sites on 
the transporter several AG varying in their aglucon moiety 
were evaluated as inhibitors of sodium-dependent D-glu- 
cose uptake into renal BBMV. AG differing in length of 
the alkyl side chain, in the configuration of attachment to
C-1 of D-glucose (axial or equatorial) and alkenylgluco- 
sides with a double bond in the side chain, which provides 
a certain limit to possible conformations, were investi- 
gated. 
3.1. The effect of alkyl side chain length 
The effect of increasing the length of the n-alkyl side 
chain is shown in Fig. 1. Whereas very short and very long 
side chains showed only a moderate inhibition, n-alkyl 
substituents ranging from 8 to 11 carbon atoms were found 
to be most effective. Maximal inhibition was achieved 
with n-nonyl-/3-D-glucoside, which inhibited Na+/D-glu - 
cose cotransport by 92% at 0.1 mM level. A local maxi- 
mum in the inhibition pattern was observed when n-hexyl- 
/3-D-glucoside was used as inhibitor. 
A possible explanation for the surprisingly low in- 
hibitory potency of AG with very long alkyl side chains 
(> 11 carbon atoms) could be an interaction of the AG 
with the lipid phase of the BBMV. The extended hy- 
drophobic parts of these molecules could lead to a partition 
of AG into the lipids thereby reducing the free inhibitor 
concentration i  the incubation media. As a consequence a 
lower inhibition per mol of AG would be observed. The 
adsorption of AG to the membranes hould be directly 
related to the total BBMV surface employed for a single 
experiment. Thus the inhibition observed should be in- 
versely related to the protein concentration. To estimate 
this effect the inhibition by fl-AG was measured under 
conditions, in which the total membrane protein (vesicle 
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Fig. 1. Inhibitory effect of n-alkyl-/3-D-glucosides (0.1 raM) increasing in 
length of the n-alkyl side chain from 1 to 13 carbon atoms on initial (5 s) 
0.1 mM D-glucose uptake into porcine renal BBMV, mean values + S.E. 
(n = 3). 
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Fig. 2. Effect of protein concentration on the inhibitory effect of n-alkyl- 
/3-D-glucosides (0.1 mM) increasing in length of the n-alkyl side chain 
from 1 to 13 carbon atoms on initial (5 s) 0.1 mM D-glucose uptake into 
porcine renal BBMV. In this experiment the ratio between the total 
amount of inhibitor in the incubation media and membrane protein 
(vesicle surface) was altered by decreasing the amount of membrane 
protein employed for a single experiment: 200 p.g (squares), 100 /xg 
(circles), 50 /zg (up triangles) and 25 ixg (down triangles) membrane 
protein. A representative experiment is shown, for the sake of clarity 
error bars are omitted, the standard eviations in this experiment were 
less than 5%. 
surface) employed for a single experiment was succes- 
sively decreased (Fig. 2). A significant dependence of the 
inhibitory effect on the amount of membrane protein could 
only be detected at a chain length above 10 carbon atoms. 
In experiments with AG with shorter side chains no effect 
was observed. 
3.2. The effect of altering anomeric onfiguration 
Measuring the inhibitory effect of fl-AG on 5 s 
sodium-dependent D-glucose uptake into BBMV compared 
to their a-anomers (Table 1) revealed a strong dependence 
on the stereochemical orientation of the substituent at C-1 
of D-glucose. Inhibition effected by equatorially oriented 
n-alkyl side chains was significantly higher than by the 
axially oriented a-analogs. The /3-configuration of the 
attachment of alkyl side chains to C-1 of D-glucose is 
Table 1 
Inhibition of sodium-dependent D-glucose uptake into porcine renal 
BBMV by ot-glucosides compared to their/3-anomers 
Glucoside (0.1 raM) Anomer Inhibition P-Value 
[% control] ot //3-anomer 
Phenylglucoside o~ 4 +_ 3 
/3 35 +_ 3 0.0O3 
Octylglucoside a 13 + 5 
/3 84 + 1 0.0002 
Decylglucoside a 39 _+ 6 
/3 92 5:1 0.0Ol 
Uptake was measured for 5 s, concentration of o-glucose and the gluco- 
sides was 0.1 mM. 
Mean values+S.E. (n= 3). The inhibitory effect of the a-anomers is 
significantly lower as indicated by the P-values. 
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Fig. 3. Chemical structures of n-hexyl-/3-D-glucoside and unsaturated 
n-hexenyl analogs. 
Table 2 
Inhibition of sodium-dependent D-glucose uptake into porcine renal 
BBMV by hexyl-/3-D-glucoside compared to the unsaturated cis- and 
trans-3-hexenyl analogs 
Glucoside (0.1 raM) Inhibition 
[% control] 
n-Hexyl-/3-D-glucoside 76 ___ l 
trans-n-3-Hexenyl-[3-glucoside 32 + 2 
cis-n-3-Hexenyl-~-glucoside 53 + 1 
Uptake was measured for 5 s, concentration of D-glucose and the gluco- 
sides was 0.1 mM. 
Mean values + S.E. (n = 3). Inhibition in the presence of the two unsatu- 
rated compounds is significantly lower than in the presence of the 
saturated compound (trans: P = 0.003, cis: P = 0.0004) and the cis 
unsaturated compound is a significantly better inhibitor than the trans- 
isomer (P  = 0.01). 
obviously favourable for an optimal interaction with the 
transporter. 
3.3. The effect of alkyl side chain flexibility 
To study the effect of side chain flexibility, the unsatu- 
rated compounds trans- and cis-3-hexenyl-fl-D-glucoside 
were synthesized; the chemical structures are shown in 
Fig. 3. Inhibition of o-glucose uptake into BBMV by both 
unsaturated sugars was significantly lower than by the 
corresponding saturated compound hexyl-/3-D-glucoside, 
moreover the cis-3-hexenyl-fl-o-glucoside was a signifi- 
cantly more effective inhibitor than the trans-isomer (Ta- 
ble 2). 
3.4. The effect of altering the sugar moiety 
It is well known that the Na+/o-glucose cotransporter 
is very sensitive to stereochemical alteration of the D-glu- 
cose C-2, thus o-mannose for example is no substrate for 
the transporter [21]. To evaluate the contribution of the 
sugar moiety of the AG for the inhibition, the inhibitory 
effect of n-octylglucoside and n-octylmannoside on D-glu- 
cose uptake was compared. As shown in Fig. 4A, octyl- 
mannoside at 0.1 mM level did not significantly interfere 
with the transport. This experiment again indicates that the 
effects of AG on D-glucose transport are not due to a 
solubilization of BBMV, since the two octyl sugars share 
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Fig. 4. (A) Effect of n-octyl-ot-D-mannoside (0.1 mM) on 5 s 0.1 mM 
D-glucose uptake into porcine renal BBMV, mean values + S.E. (n = 3). 
(B) Inhibitory effect of 0, 30, 60 and 90 ~M n-octyl-fl-D-glucoside on 5 
sec D-glucose uptake into porcine renal BBMV measured at two substrate 
concentrations, 0.1 mM (squares) and 0,2 mM (circles) D-glucose, accord- 
ing to the method of Dixon. A representative experiment is shown. From 
three such experiments a K i of 10_+ 2 /xM was calculated. 
the same non-ionic detergent potential with an identical 
critical micelle concentration f 30 mM. More importantly, 
however, the results suggest hat the sugar moiety posi- 
tions the alkyl chains to be able to exert their action. The 
importance of the interaction of the AG with the sugar 
binding site is also evident from the Dixon plot shown in 
Fig. 4B. In the concentration range tested the inhibition of 
o-glucose uptake by /3-octyl-D-glucoside exhibits a fully 
competitive inhibition with regard to D-glucose. 
3.5. Effects of alkylglucosides on other BBMV properties 
At high concentrations AG are effective non-ionic de- 
tergents, thus the inhibition of glucose uptake observed in 
our studies might have been due to solubilization of mem- 
brane vesicles. Therefore the effect of representative AG 
on equilibrium D-glucose uptake was investigated (Table 
3). At 0.1 mM the D-glucose uptake even after 90 min of 
Table 3 
Effect of representative alkylglucosides on equilibrium D-glucose uptake 
into porcine renal BBMV 
Glucoside (0.1 mM) Gradient 90 min uptake 
[pmol/mg] 
Control Na 203 _+ 25 
Control K 180 +__ 21 
Methyl-fl-o-glucoside Na 185 + 12 
n-Nonyl-fl-D-glucoside Na 196 + 16 
n-Tridecyl-fl-D-glucoside Na 194_+ 27 
Uptake was measured for 90 min, concentration of D-glucose and the 
glucosides was 0.1 mM. The equilibrium is indicated by the same 
D-glucose uptake rates in the presence of a sodium or a potassium 
gradient across the membrane vesicles in the control experiments. 
Mean values+ S.E. (n = 3). 
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Table 4 
Effect of representative alkylglucosides on sodium-dependent and 
sodium-independent L-alanine uptake into porcine renal BBMV 
Glucoside (0.1 mM) Na independent Na dependent 
[pmol/mg] [pmol/mg] 
Control 70 + 4 84 + 9 
Methyl-/3-D-glucoside 63 + 5 97 + 6 
n-Nonyl-fl-D-glucoside 66 + 5 102 + 4 
n-Tridecyl-/3-D-glucoside 67 + 10 116+ 16 
Uptake was measured for 5 s, concentration of L-alanine and the gluco- 
sides was 0.1 mM. 
Mean values +S.E. (n = 3), 
incubation was the same in the absence and presence of 
AG. This indicated no alteration of the intravesicular space. 
Similarly, sodium-independent as well as sodium-depen- 
dent L-alanine uptake was not inhibited by AG, the 
sodium-dependent L-alanine transporter showed even a 
slight although not significant increase in transport activity 
(Table 4). These data suggest hat an alteration of general 
BBMV properties, such as vesicle size or membrane per- 
meability, due to a detergent action of 0.1 mM AG can be 
excluded. 
4. Discussion 
4.1. Unspecific effects of AG 
The amphiphilic character of AG with a hydrophilic 
sugar moiety and a hydrophobic glucoside side chain 
makes them effective non-ionic detergents. The distribu- 
tion of these properties along the molecule also makes 
them potent inhibitors for the renal Na+/D-glucose co- 
transporter by simultaneous interactions with the glucose 
recognition site and hydrophobic domains at the trans- 
porter molecule. Since solubilization of membrane proteins 
by AG is commonly achieved at high concentrations (n-oc- 
tyl-/3-D-glucoside for example has a critical micelle con- 
centration of 30 mM), we have performed our experiments 
at low inhibitor concentrations of maximal 0.1 mM. To 
further exclude a detergent action we have limited our 
investigations to AG with n-alkyl side chains no longer 
than 13 carbon atoms and have used short incubation times 
(5 s) for the measurement of substrate uptakes. Within 
these limits no evidence for a vesicle disruption or an 
alteration of general BBMV properties due to a detergent 
action of AG has been found. In the presence of AG the 
L-alanine transport system present in BBMV was not 
affected and the equilibrium D-glucose uptake into BBMV 
indicated no alterations in intravesicular space. The in- 
hibitory effect of AG with side chains longer than 10 
carbon atoms is dependent on the amount of membrane 
protein (vesicle surface) used for a single experiment, 
which could be explained by a partial adsorption of the 
inhibitor to lipids of the vesicle surface mediated via the 
hydrophobic tail. However, AG with side chains up to 10 
carbon atoms did not show this effect. 
4.2. Effects of AG on the D-glucose transporter 
Ramaswamy et al. [13] tested a series of /3-n-AG with 
increasing length of the side chain as substrates for 
sodium-dependent translocation i  the hamster small in- 
testinal epithelium in vitro. Methyl and ethylglucoside 
were well translocated while n-butylglucoside was trans- 
ported to a lesser extent and transport continued to dimin- 
ish with increasing length of the AG side chain. An 
apparent increase of translocation activity of AG with very 
long alkyl chains (> 10 carbon atoms) can be considered 
as an artefact due to an increased solubility of these 
compounds in the tissue. In our experiments also a signifi- 
cant binding of AG to the membranes was observed for 
chain lengths > 10 carbons. This indicates that transloca- 
tion of AG by the Na+/D-glucose cotransporter is limited 
by the size of the glucoside side group, thus too bulky side 
groups at C-t prevent ranslocation. This observation is 
also supported by further work of Ramaswamy et al. [22] 
in which they demonstrated that 1-O-alkylglucosides are 
translocated up to a chain length of 4 carbon atoms, but 
that 1-O-acylglucosides with an additional carbonyl func- 
tion at C-1 of the side chain do not undergo translocation, 
although being inhibitors for the transporter. 
This previous work suggests that in our inhibitor studies 
also AG longer than n-butylglucoside o not compete with 
D-glucose for the translocation steps across the membrane. 
D-Glucose uptake into BBMV is more likely inhibited by 
binding of AG to the outwardly facing D-glucose binding 
site of the cartier with high affinity and thereby blocking 
D-glucose transport. This mode of AG interaction parallels 
the inhibitory effect of the well established inhibitor phlo- 
rizin on sodium-dependent D-glucose transport. 
As shown in kinetic analysis according to the method of 
Dixon, n-octylglucoside is a fully competitive inhibitor of 
renal Na+/D-glucose cotransport with an apparent K i of 
10 + 2 /zM with regard to o-glucose, which at first glance 
is surprising. Octylglucoside presumably binds not only to 
the D-glucose recognition site of the transporter molecule 
but interacts with hydrophobic sites as well and for such 
inhibitors interacting with multiple binding sites a mixed 
type of inhibition should be expected. This contradiction 
can be explained by assuming a two-step rocess for AG 
binding to the transporter. In the first, most important step 
the D-glucose moiety is recognized by the transporter and 
in a second step the AG side chain is positioned for the 
interaction with hydrophobic sites of the carrier. The pre- 
dominant feature in this two-step mechanism is the binding 
of the D-glucose moiety to the substrate binding site which 
explains the fully competitive inhibition kinetic found. 
This assumption is also supported by the observation that 
octylmannoside lacks any inhibitory potential on Na+/o - 
glucose cotransport, since it has a sugar moiety unable to 
H. Kipp et al. / Biochimica et Biophysica Acta 1282 (1996) 124-130 129 
bind to the receptor. The intensity of interaction of AG 
with hydrophobic sites of the transporter molecule after 
binding of the D-glucose moiety was found to be strongly 
dependent on the properties of the side group and its 
structural relationship with regard to the plane of the 
pyranose ring of D-glucose, namely the anomeric onfigu- 
ration, length and flexibility of the alkyl chain were limit- 
ing factors for the inhibitory potential. 
fl-AG with an equatorially oriented substituent a C-1 of 
D-glucose were far more effective inhibitors of Na+/D -
glucose cotransport compared to the corresponding com- 
pounds with an axially oriented side group. Side groups 
oriented perpendicularly to the plane of the D-glucose 
pyranose ring in the ~-anomers eem either to interfere 
with proper binding of the sugar moiety to the D-glucose 
binding site or this stereochemical arrangement interferes 
with access of the alkyl groups to hydrophobic transporter 
sites, thereby decreasing their affinity. Beside steric con- 
strains due to bulky substituents, it may also be possible 
that there is an H-bond to the oxygen at C-1 in the 
r-position, which cannot be established with the axial 
oxygen of the a-anomers. These findings are also consis- 
tent with earlier observations that both r-methyl- and 
fl-phenylglucoside are more potent inhibitors for sodium- 
coupled phlorizin binding to rat kidney BBMV [23] and 
that fl-2-naphtylglucoside is the preferred substrate for 
sodium dependent intestinal absorption in rat [24] com- 
pared to the respective t~-AG. 
The degree of D-glucose uptake inhibition observed in 
the current study by different fl-AG was dependent on the 
length of the alkyl side chain, thus fl-AG with very short 
( < 8 carbon atoms) or very long side chains (> 11 carbon 
atoms) showed only a moderate inhibition. Whereas the 
low inhibition of/3-AG with short alkyl side chains can be 
explained by the lack of access to hydrophobic transporter 
sites due to the limited size, one has to consider more than 
one effect for the low inhibition of /3-AG with long alkyl 
side chains. Most important is the decrease of free in- 
hibitor concentration i the incubation media due to mi- 
celle formation and adsorption of inhibitor at the vesicle 
surface. The critical micelle concentration for fl-n-tridecyl- 
glucoside can be estimated to be 0.1 mM [25] and is only 
for this compound in the same concentration range where 
the inhibitor studies were performed (0.1 mM). Thus the 
decrease of the free inhibitor concentration i  the incuba- 
tion media due to micelle formation could be possible to a 
very low extent only for the highest homolog tested. The 
critical micelle concentration for all the other compounds 
is higher than 0.1 mM (fl-n-dodecylglucoside 0.2 raM, 
/3-n-undecylglucoside 0.7 mM, /3-n-decylglucoside 2 raM, 
/3-n-nonylglucoside 8 mM, etc. [25]) and a micelle forma- 
tion can be excluded. For the compounds with alkyl groups 
longer than 10 carbon atoms, a partial adsorption at the 
lipids of the vesicle surface has also to be considered, as 
demonstrated by the protein dependence of the inhibitory 
effect. Whether this is the only effect responsible for the 
dramatic decrease of inhibitor potential from fl-n-undecyl- 
glucoside to fl-n-tridecylglucoside is not quite clear. In 
addition, it might be possible that very long alkyl side 
chains assuming a randomly coiled conformation are too 
bulky to fit into the binding pocket of the transporter. The 
size of the side group, which supports an optimal interac- 
tion of both D-glucose moiety and side chain with the 
different functional domains of the cartier, is a length from 
8 to 11 carbon atoms, since these compounds were the 
most effective inhibitors tested. A possible explanation for 
the observed local maximum in the inhibition pattern (see 
Fig. 1) could be an interaction of the alkyl side chain with 
two distinct hydrophobic sites of the transporter. The one 
next to the glucose binding site exhibits optimal interaction 
with a n-hexyl residue. A further elongation of the side 
chain leads to a transient net loss of affinity until an 
optimal interaction with the two hydrophobic sites is 
achieved. 
Since it is difficult to predict he conformational state of 
AG side chains while interacting with the transporter 
molecule, we have tried to approach this question by 
investigating the inhibitory potential of AG analogs with a 
double bond in the alkyl side chain. The side chains of the 
two unsaturated hexylglucoside analogs, trans- and cis-n- 
hex-3-enyl-/3-o-glucoside, ar  limited in their possible con- 
formations, because there is no rotation around the side 
chain bond between C-3 and C-4 (see Fig. 3). Whereas the 
t rans- isomer exhibits a conformation of the side chain with 
a more straight character, the cis- isomer prefers a confor- 
mation which is more coiled. The two unsaturated com- 
pounds were significantly less effective inhibitors of 
Na+/D-glucose cotransport than the hexylglucoside, indi- 
cating the importance of side chain flexibility for optimal 
interaction with the hydrophobic sites on the transporter. 
Moreover the unsaturated cis- isomer was a significantly 
more effective inhibitor than the trans- isomer.  These data 
suggest hat a coiled conformation of the alkyl side chain 
favors the access to hydrophobic sites on the transporter. 
Computer supported conformational analysis using force 
field methods revealed that in their most likely conformers 
the aglucone parts of fl-AG and phlorizin seem to point to 
different directions when bound to the glucose binding site 
of the transporter (S. Wielert, unpublished results). Thus it 
is possible that these two types of inhibitors gain their 
additional binding to the transporter by Van der Waal's 
interaction of their non-sugar moieties with completely 
different hydrophobic sites of the transporter, in view of 
the uncertainties of such modelling studies, however, di- 
rect labelling studies are necessary to clarify this question. 
Our present study demonstrates that alkylglucosides are 
remarkable inhibitors for the renal Na+/D-glucose cotrans- 
porter as long as a few structural requirements are met. 
The /3-configuration, the flexibility and the choice of an 
appropriate l ngth of the alkyl side chain, ranging from 8 
to 11 carbon atoms, are necessary to obtain an optimal 
interaction. Compared to the classical inhibitor phlorizin 
130 H. Kipp et al. / Biochimica et Biophysica Acta 1282 (1996) 124-130 
AG exhibit a relatively simple chemical structure, which 
makes them interesting tools to study the assembly of 
different functional domains on the Na+/D-glucose co- 
transporter. Moreover, AG provide an ideal starting mate- 
rial for chemical modifications to obtain suitable photola- 
bile affinity labels for the transporter, a project presently 
pursued in our laboratory. 
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